SCHEMBL7148208

SCHEMBL7148208

COc1ccc(N(OC)C(=O)CN2C(=O)c3ccccc3C2=O)cc1

nearest known ligand 0.61

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 1/20 0.61
▸ RPS6KA2 Q15349 2/20 0.58
▸ ALDH1A1 P00352 3/20 0.56
▸ RAB9A P51151 2/20 0.52
▸ KMT2A Q03164 2/20 0.51
▸ GAA P10253 2/20 0.51
▸ TDP1 Q9NUW8 2/20 0.51
▸ HSD17B10 Q99714 2/20 0.50
▸ MEN1 O00255 1/20 0.50
▸ MAPT P10636 2/20 0.49
▸ NPSR1 Q6W5P4 1/20 0.49
▸ POLB P06746 2/20 0.48
▸ APEX1 P27695 1/20 0.48
▸ CASP3 P42574 1/20 0.48
▸ THRB P10828 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9471237 0.84 NPC1 (0.61) NPC1RPS6KA2ALDH1A1RAB9AKMT2A
SCHEMBL9133596 0.81 ALDH1A1 (0.59) NPC1RPS6KA2ALDH1A1RAB9AKMT2A
SCHEMBL9159392 0.77 ALDH1A1 (0.55) NPC1RPS6KA2ALDH1A1RAB9AKMT2A
SCHEMBL9134088 0.77 ALDH1A1 (0.54) NPC1RPS6KA2ALDH1A1RAB9AKMT2A
SCHEMBL1609155 0.76 NPC1 (1.00) NPC1RPS6KA2ALDH1A1RAB9AKMT2A
SCHEMBL9159221 0.73 MEN1 (0.52) NPC1RPS6KA2ALDH1A1RAB9AKMT2A
SCHEMBL29398039 0.72 L3MBTL1 (0.63) NPC1ALDH1A1RAB9AKMT2AGAA
SCHEMBL8828063 0.71 RAB9A (0.49) NPC1ALDH1A1RAB9AKMT2AGAA
SCHEMBL28610800 0.70 ALDH1A1 (0.77) NPC1ALDH1A1KMT2AMEN1POLB
SCHEMBL876385 0.69 MMP2 (0.59) NPC1RPS6KA2ALDH1A1RAB9AKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1035848-B1 SUBSTITUTED ALKANOHYDROXAMIC ACIDS AND METHOD OF REDUCING TNF-ALPHA LEVELS CELGENE CORP (US) 2003-04-23 — — EP claimed
EP-1035848-B1 SUBSTITUTED ALKANOHYDROXAMIC ACIDS AND METHOD OF REDUCING TNF-ALPHA LEVELS CELGENE CORP (US) 2003-04-23 — — EP disclosed
Send feedback